Figure 1From: Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients Toxicity profile of the 45 patients with severe toxicity treated with 5-FU according to Common Terminology Criteria for Adverse Events, v4.0.Back to article page